1. Home
  2. DAC vs RCUS Comparison

DAC vs RCUS Comparison

Compare DAC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

N/A

Current Price

$148.77

Market Cap

3.0B

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$18.28

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAC
RCUS
Founded
1972
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
DAC
RCUS
Price
$148.77
$18.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
★ $164.50
$41.00
AVG Volume (30 Days)
137.1K
★ 2.5M
Earning Date
11-20-2026
11-04-2026
Dividend Yield
★ 2.42%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $247,000,000.00
Revenue This Year
$3.24
N/A
Revenue Next Year
$1.63
N/A
P/E Ratio
$4.01
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$92.02
$17.43
52 Week High
$172.76
$31.74

Technical Indicators

Market Signals
Indicator
DAC
RCUS
Relative Strength Index (RSI) 30.48 37.67
Support Level $122.39 $17.97
Resistance Level $152.98 $24.46
Average True Range (ATR) 3.26 1.59
MACD -1.31 0.09
Stochastic Oscillator 7.72 13.41

Price Performance

Historical Comparison
DAC
RCUS

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: